Cell therapies are among the most promising, yet complex medicines being developed today. Multiply Labs' mission is to make these therapies more widely available by increasing manufacturing efficiency ...
Robotic biomanufacturing company Multiply Labs said it has made a significant advance toward its goal of scaling production of cell and gene therapies by using Nvidia’s open Isaac and GR00T robotics ...
LONDON, Feb. 5, 2026 /PRNewswire/ -- EX3, a strategic SAP partner and global provider of payroll and HR solutions, today announced the launch of EX3 AI Labs, a dedicated innovation hub designed to ...
(MENAFN- Robotics & Automation News) Multiply Labs has reached an agreement with pharmaceutical giant AstraZeneca to evaluate the potential for applying GMP (Good Manufacturing Practices)-ready ...
SANTA CLARA, CA / ACCESS Newswire / February 4, 2026 / Expert Intelligence™, a startup building AI systems that automate expert decision-making in regulated laboratory environments, today announced it ...
Traditional processes used to discover new materials are complex, time-consuming, and costly, often requiring years of sustained effort. Recent advances in large language models (LLMs) have ...
Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology SAN FRANCISCO--(BUSINESS WIRE)--#AstraZeneca--Multiply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results